Breaking News

Fujifilm, Mitsubishi in Bio-CMO Pact

Mitsubishi to gain 20% equity in new bio-CMO network, add global sales and marketing

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Fujifilm and Mitsubishi have entered into a partnership in for biopharma contract manufacturing. The companies have signed an agreement to transfer the ownership of 20% equity interests in Fujifilm’s wholly-owned biopharmaceutical contract manufacturing subsidiaries, Fujifilm Diosynth Biotechnologies U.S.A. Inc. (FDBUS) and FUJIFILM Diosynth Biotechnologies UK Limited (FDBUK), to Mitsubishi Corporation. Mitsubishi Corporation will become involved in the business management of FDBUS and FDB...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters